A Century After the Eugenics Movement, the U.S. Is Again Barring Disabled Immigrants
By Emma Cieslik,
Ms. Magazine
| 11. 20. 2025
A revived “public charge” standard directs officers to deny visas to people with disabilities, chronic illnesses and age-related conditions—echoing the exclusionary policies of the early 20th century.
Photo by The New York Public Library on Unsplash
This piece includes sanist slurs used in the late 19th and early 20th centuries.
This month, Secretary of State Marco Rubio instructed visa officers to consider obesity and other chronic health conditions, such as heart disease, cancer and diabetes, as justification to deny people visas to the United States. The guidance—along with direction that visa officers can reject visa applications for people beyond retirement age and if their dependents are elderly or disabled—is part of a “public charge” rulethat allows the government to deny visas and green cards if the person might use social welfare programs or be institutionalized.
Many were outraged and shocked, observing the Trump administration’s new expansion of the “public charge” rule—directing visa officers to deny entry to people with disabilities, chronic illnesses or age-related conditions—as a modern revival of eugenic immigration policy designed to exclude, control and institutionalize disabled and marginalized people. The “public charge” rule is not new, but this new definition seeks to restrict citizenship on the basis of possible institutionalization as the Trump...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Garrett Owen, Salon | 03.18.2026